Effect of Once-Per-Day Tacrolimus vs Twice-Per-Day Ciclosporin on 3-Year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial
Lancet Respir Med 2023 Sep 10;[EPub Ahead of Print], G Dellgren, TK Lund, P Raivio, I Leuckfeld, J Svahn, EC Holmberg, PS Olsen, M Halme, A Fiane, S Lindstedt, GC Riise, J MagnussonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.